Cargando…
Roles for growth factors and mutations in metastatic dissemination
Cancer is initiated largely by specific cohorts of genetic aberrations, which are generated by mutagens and often mimic active growth factor receptors, or downstream effectors. Once initiated cells outgrow and attract blood vessels, a multi-step process, called metastasis, disseminates cancer cells...
Autores principales: | Nataraj, Nishanth Belugali, Marrocco, Ilaria, Yarden, Yosef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286841/ https://www.ncbi.nlm.nih.gov/pubmed/34100888 http://dx.doi.org/10.1042/BST20210048 |
Ejemplares similares
-
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators
por: Marrocco, Ilaria, et al.
Publicado: (2023) -
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
por: Marrocco, Ilaria, et al.
Publicado: (2021) -
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
por: Uribe, Mary Luz, et al.
Publicado: (2021) -
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor
por: Romaniello, Donatella, et al.
Publicado: (2020) -
Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53
por: Lindzen, Moshit, et al.
Publicado: (2021)